CLDX vs ICCC
Celldex Therapeutics, Inc. - Common Stock · ImmuCell Corporation - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CLDX | ICCC |
|---|---|---|
| Price | $30.15 | $10.19 |
| Market Cap | $2.37B | $92.55M |
| P/E | — | — |
| P/B | 3.65 | 2.95 |
| P/S | 1532.77 | 3.35 |
| ROE | -39.8% | -3.3% |
| Net Margin | -16748.0% | -3.8% |
| Gross Margin | — | 41.4% |
| Revenue Growth | -78.0% | 4.3% |
| Dividend Yield | — | — |
| EPS | -$3.29 | -$0.11 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.